Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea

Soluble RAGE in COPD, with or without coexisting obstructive sleep apnoea

Abstract Background Hypoxia can reduce the levels of soluble receptor for advanced glycation end-products (sRAGE), a new anti-inflammatory biomarker of COPD. We assessed sRAGE in patients with hypoxia-related diseases such as COPD, OSA and OSA-COPD overlap. Methods Plasma levels of sRAGE were measur...

Full description

Bibliographic Details
Main Authors:	Marta Marin-Oto, David Sanz-Rubio, Fernando Santamaría-Martos, Ivan Benitez, Ana L. Simon, Marta Forner, Pablo Cubero, Ana Gil, Manuel Sanchez-de-laTorre, Ferran Barbe, José M. Marin
Format:	Article
Language:	English
Published:	BMC 2022-06-01
Series:	Respiratory Research
Subjects:	sRAGE Smokers Chronic obstructive pulmonary disease Obstructive sleep apnoea
Online Access:	https://doi.org/10.1186/s12931-022-02092-9

Similar Items

Assessment of EN-RAGE, sRAGE and EN-RAGE/sRAGE as potential biomarkers in patients with autoimmune hepatitis
by: Rui Wu, et al.
Published: (2020-10-01)

Involvement of RAGE and Oxidative Stress in Inflammatory and Infectious Skin Diseases
by: Fabrizio Guarneri, et al.
Published: (2021-01-01)

Soluble Receptor for Advanced Glycation End Products (sRAGE) is Up-Regulated in Multiple Sclerosis Patients Treated with Interferon β-1a
by: Mahnoosh Rahimi, et al.
Published: (2018-03-01)

Polymorphisms −374 T/A and −429 T/C of the Receptor for Advanced Glycation End-Products (RAGE) and Serum Levels of RAGE (sRAGE) Are Not Associated with Metabolic Syndrome
by: Diana Elizabeth González-Guerrero, et al.
Published: (2023-04-01)

Soluble Receptor for Advanced Glycation End Products (sRAGE) Level and Its Prognostic Significance in Children with Acute Lymphoblastic Leukemia
by: Busra Ozkan, et al.
Published: (2024-01-01)

Soluble Receptor of Advanced Glycation End-Products (sRAGE) in Pediatric Asthma: A Prospective Study in 68 Children Aged 7 Years
by: Julie Magnier, et al.
Published: (2022-06-01)

Plasma sRAGE levels strongly associate with centrilobular emphysema assessed by HRCT scans
by: Frank Klont, et al.
Published: (2022-01-01)

G82S RAGE polymorphism is associated with Alzheimer’s disease
by: Rani Cathrine Chellappa, et al.
Published: (2020-03-01)

Capsaicin, an active ingredient from chilli peppers, attenuates glycative stress and restores sRAGE levels in diabetic rats
by: Shih-Min Hsia, et al.
Published: (2016-03-01)

Concentrations of N<sup>6</sup>-Carboxymethyllysine (CML), N<sup>6</sup>-Carboxyethyllysine (CEL), and Soluble Receptor for Advanced Glycation End-Products (sRAGE) Are Increased in Psoriatic Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2022-12-01)

The Assessment of Serum Concentrations of AGEs and Their Soluble Receptor (sRAGE) in Multiple Sclerosis Patients
by: Aleksandra Damasiewicz-Bodzek, et al.
Published: (2021-07-01)

Effect of irisin on metabolic and platelet functions in type 2 diabetic rats: role of soluble receptor of advanced glycation end products (sRAGE)
by: Sherif W. Mansour, et al.
Published: (2021-10-01)

Could AGE/RAGE-Related Oxidative Homeostasis Dysregulation Enhance Susceptibility to Pathogenesis of Cardio-Metabolic Complications in Childhood Obesity?
by: Domenico Corica, et al.
Published: (2019-06-01)

OBSTRUCTIVE SLEEP APNOEA IN CHILDREN
by: Nina Božanić Urbančič
Published: (2020-09-01)

S100A8/A9 and sRAGE kinetic after polytrauma; an explorative observational study
by: Philippe Joly, et al.
Published: (2017-11-01)

Endogenous Secretory RAGE as a Novel Biomarker for Metabolic Syndrome and Cardiovascular Diseases
by: Hidenori Koyama, et al.
Published: (2007-01-01)

Treatment of obstructive and central sleep apnoea in heart failure: practical options
by: S. Javaheri
Published: (2007-12-01)

Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease
by: Farida Dakterzada, et al.
Published: (2023-08-01)

Plasma Levels of Free <i>N</i><i><sup>Ɛ</sup></i>-Carboxymethyllysine (CML) after Different Oral Doses of CML in Rats and after the Intake of Different Breakfasts in Humans: Postprandial Plasma Level of sRAGE in Humans
by: Cynthia Helou, et al.
Published: (2022-04-01)

Huge Epiglottic Cyst Presenting as Obstructive Sleep Apnoea
by: Agarwal V, et al.
Published: (2015-07-01)

Pathophysiology of obstructive sleep apnoea syndrome: a review
by: Al Riyami B, et al.
Published: (2000-10-01)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
by: Lara Caldiroli, et al.
Published: (2022-06-01)

Soluble receptor for advanced glycation end products (sRAGE) is associated with obesity rates: a systematic review and meta-analysis of cross-sectional study
by: Nahla A Tayyib, et al.
Published: (2023-12-01)

Effects of inspiratory muscle training in patients with obstructive sleep apnoea syndrome: a systematic review and meta-analysis
by: Javid Ahmad Dar, et al.
Published: (2022-12-01)

Significant Interrelations among Serum Annexin A1, Soluble Receptor for Advanced Glycation End Products (sRAGE) and rs2070600 in Chronic Obstructive Pulmonary Disease
by: Amira A. Kamel, et al.
Published: (2022-11-01)

Soluble receptor for advanced glycation end products (sRAGE) and carotid intima-media thickness (CIMT) in type 1 diabetes Mellitus: Possible association with diabetic vascular complications
by: Eman M. Sherif, et al.
Published: (2014-10-01)

P.39 The Role of Advanced Glycation End Products in Vascular Ageing. Which Parameter is the Most Suitable as Biomarker?
by: Otto Mayer, et al.
Published: (2020-12-01)

Coagulation and Fibrinolysis in Obstructive Sleep Apnoea
by: Andras Bikov, et al.
Published: (2021-03-01)

Reticulocytes in untreated Obstructive Sleep Apnoea
by: O. Marrone, et al.
Published: (2016-01-01)

Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes
by: Beatriz Martín-Carro, et al.
Published: (2023-03-01)

High levels of soluble RAGE are associated with a greater risk of mortality in COVID-19 patients treated with dexamethasone
by: Lee Butcher, et al.
Published: (2022-11-01)

Effects of acute aerobic exercise on circulating sTLR and sRAGE profiles in normal‐ and abnormal‐glucose‐tolerant individuals
by: Ryan K. Perkins, et al.
Published: (2023-11-01)

AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
by: Paolo Molinari, et al.
Published: (2021-12-01)

Blood-based lipidomic signature of severe obstructive sleep apnoea in Alzheimer’s disease
by: Farida Dakterzada, et al.
Published: (2022-11-01)

Obstructive Sleep Apnoea Syndrome and Cardiac Arrhythmia
by: Onur Yıldız, et al.
Published: (2020-12-01)

Nomogram to diagnosis of obstructive sleep apnoea‐hypopnoea syndrome in high‐risk Chinese adult patients
by: Jie Liu, et al.
Published: (2023-09-01)

Assessing Pulmonary Epithelial Damage in Hantavirus Cardiopulmonary Syndrome: Challenging the Predominant Role of Vascular Endothelium through sRAGE as a Potential Biomarker
by: Gabriela Meza-Fuentes, et al.
Published: (2023-09-01)

The neuropharmacology of upper airway motor control in the awake and asleep states: implications for obstructive sleep apnoea
by: Horner Richard L
Published: (2001-08-01)

Obstructive sleep apnoea and cardiovascular disease: a literature review
by: Hussein Assallum, et al.
Published: (2019-10-01)

The Recent View on the Obstructive Sleep Apnoea Syndrome in Children – Short Résumé
by: Sujanska A, et al.
Published: (2012-12-01)